80 related articles for article (PubMed ID: 8701402)
1. Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Galli M; Grassi A; Barbui T
Thromb Haemost; 1996 Mar; 75(3):427-31. PubMed ID: 8701402
[TBL] [Abstract][Full Text] [Related]
2. Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Neuman L; Joseph A; Bouzid R; Lescroart M; Mariotte E; Ederhy S; Tuffet S; Baudel JL; Benhamou Y; Galicier L; Grangé S; Provôt F; Neel A; Pène F; Delmas Y; Presne C; Poullin P; Wynckel A; Perez P; Barbet C; Halimi JM; Chatelet V; Rebibou JM; Ojeda-Uribe M; Vigneau C; Mesnard L; Veyradier A; Azoulay E; Coppo P; Chabriat H;
J Neurol; 2023 Oct; 270(10):5023-5033. PubMed ID: 37392208
[TBL] [Abstract][Full Text] [Related]
3. Undiagnosed Metastatic Breast Carcinoma Presenting as Thrombotic Thrombocytopenic Purpura.
Jackson DL; Coke L; Oni O; Taddesse-Heath L
Cureus; 2023 Aug; 15(8):e44452. PubMed ID: 37791199
[TBL] [Abstract][Full Text] [Related]
4. Renal Involvement in Thrombotic Thrombocytopenic Purpura: Is It Time to Challenge the Old Paradigm?
Issa L; Sandakly N; El Koubayati G; Khalil M; Haddad F
Cureus; 2024 May; 16(5):e60259. PubMed ID: 38872662
[TBL] [Abstract][Full Text] [Related]
5. Lessons learned from hemolytic uremic syndrome registries: recommendations for implementation.
Lazem M; Sheikhtaheri A; Hooman N
Orphanet J Rare Dis; 2021 May; 16(1):240. PubMed ID: 34034793
[TBL] [Abstract][Full Text] [Related]
6. Validation of flow cytometric detection of platelet microparticles and liposomes by atomic force microscopy.
Leong HS; Podor TJ; Manocha B; Lewis JD
J Thromb Haemost; 2011 Dec; 9(12):2466-76. PubMed ID: 21981726
[TBL] [Abstract][Full Text] [Related]
7. The potential applications of microparticles in the diagnosis, treatment, and prognosis of lung cancer.
Liu Y; Wang S; Xia H; Tan X; Song S; Zhang S; Meng D; Chen Q; Jin Y
J Transl Med; 2022 Sep; 20(1):404. PubMed ID: 36064415
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of Coagulation and Emerging Roles for Extracellular Vesicles in Coagulation Cascades and Disorders.
Al-Koussa H; AlZaim I; El-Sabban ME
J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013171
[TBL] [Abstract][Full Text] [Related]
9. Blood Cell-Derived Microvesicles in Hematological Diseases and beyond.
Georgatzakou HT; Fortis SP; Papageorgiou EG; Antonelou MH; Kriebardis AG
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740926
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence.
Zifkos K; Dubois C; Schäfer K
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502228
[TBL] [Abstract][Full Text] [Related]
11. Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.
Yeung J; Li W; Holinstat M
Pharmacol Rev; 2018 Jul; 70(3):526-548. PubMed ID: 29925522
[TBL] [Abstract][Full Text] [Related]
12. Platelet-Derived Microvesicles in Cardiovascular Diseases.
Zaldivia MTK; McFadyen JD; Lim B; Wang X; Peter K
Front Cardiovasc Med; 2017; 4():74. PubMed ID: 29209618
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles and blood diseases.
Nomura S
Int J Hematol; 2017 Apr; 105(4):392-405. PubMed ID: 28130731
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3.
Liang H; Yan X; Pan Y; Wang Y; Wang N; Li L; Liu Y; Chen X; Zhang CY; Gu H; Zen K
Mol Cancer; 2015 Mar; 14():58. PubMed ID: 25881295
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles.
Ståhl AL; Arvidsson I; Johansson KE; Chromek M; Rebetz J; Loos S; Kristoffersson AC; Békássy ZD; Mörgelin M; Karpman D
PLoS Pathog; 2015 Feb; 11(2):e1004619. PubMed ID: 25719452
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of procoagulant microparticles.
Nomura S; Shimizu M
J Intensive Care; 2015; 3(1):2. PubMed ID: 25705427
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of microparticles from platelets and megakaryocytes.
Italiano JE; Mairuhu AT; Flaumenhaft R
Curr Opin Hematol; 2010 Nov; 17(6):578-84. PubMed ID: 20739880
[TBL] [Abstract][Full Text] [Related]
18. Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.
Ståhl AL; Sartz L; Nelsson A; Békássy ZD; Karpman D
PLoS One; 2009 Sep; 4(9):e6990. PubMed ID: 19750223
[TBL] [Abstract][Full Text] [Related]
19. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles.
Flaumenhaft R; Dilks JR; Richardson J; Alden E; Patel-Hett SR; Battinelli E; Klement GL; Sola-Visner M; Italiano JE
Blood; 2009 Jan; 113(5):1112-21. PubMed ID: 18802008
[TBL] [Abstract][Full Text] [Related]
20. Cell damage at the origin of antiphospholipid antibodies and their pathogenic potential in recurrent pregnancy loss.
Piroux V; Eschwège V; Freyssinet JM
Infect Dis Obstet Gynecol; 1997; 5(2):176-80. PubMed ID: 18476171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
